POTASSIUM for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 27 adverse event reports in the FDA FAERS database where POTASSIUM was used for Psoriasis.
Most Reported Side Effects for POTASSIUM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,115 | 9.3% | 117 | 596 |
| Hyperkalaemia | 944 | 7.9% | 124 | 611 |
| Off label use | 789 | 6.6% | 185 | 572 |
| Nausea | 747 | 6.2% | 166 | 492 |
| Dyspnoea | 711 | 5.9% | 134 | 486 |
| Diarrhoea | 690 | 5.8% | 65 | 239 |
| Malaise | 678 | 5.7% | 43 | 396 |
| Abdominal pain | 636 | 5.3% | 148 | 367 |
| Acute kidney injury | 614 | 5.1% | 81 | 409 |
| Vomiting | 588 | 4.9% | 183 | 259 |
| Somnolence | 586 | 4.9% | 130 | 488 |
| Fatigue | 575 | 4.8% | 31 | 180 |
| Dizziness | 512 | 4.3% | 7 | 199 |
| Constipation | 491 | 4.1% | 152 | 377 |
| Pyrexia | 473 | 4.0% | 57 | 372 |
Other Indications for POTASSIUM
Product used for unknown indication (5,115)
Hypokalaemia (1,667)
Blood potassium decreased (404)
Mineral supplementation (363)
Parenteral nutrition (294)
Constipation (159)
Nephrolithiasis (156)
Electrolyte substitution therapy (137)
Cystinuria (111)
Prophylaxis (93)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)